"Small cell networks" trang 1 - tải miễn phí từ tailieunhanh
Ebook Massive MIMO meets small cell: Backhaul and cooperation

Ebook Massive MIMO meets small cell: Backhaul and cooperation
69    13    1
Long noncoding RNA POU3F3 enhances cancer cell proliferation, migration and invasion in non-small cell lung cancer (adenocarcinoma) by downregulating microRNA-30d-5p

Long noncoding RNA POU3F3 enhances cancer cell proliferation, migration and invasion in non-small cell lung cancer (adenocarcinoma) by downregulating microRNA-30d-5p
8    41    1
Study on PET/CT findings in patients with small cell lung cancer

Study on PET/CT findings in patients with small cell lung cancer
9    109    0
TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location

TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location
10    57    1
A population-based study of incidence and patient survival of small cell carcinoma in the United States, 1992–2010

A population-based study of incidence and patient survival of small cell carcinoma in the United States, 1992–2010
10    41    1
Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: An exploratory longitudinal study

Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: An exploratory longitudinal study
9    59    3
The result of adjuvant vinorelbine plus cisplatin in completely resected stage IB-IIIA non-small cell lung cancer at Hanoi Medical University Hospital

The result of adjuvant vinorelbine plus cisplatin in completely resected stage IB-IIIA non-small cell lung cancer at Hanoi Medical University Hospital
6    46    1
Results of concurrent chemoradiotherapy of 30 patients with inoperable stage III non-small cell lung cancer, used PET/CT planning radiation plan at 108 Military Central Hospital

Results of concurrent chemoradiotherapy of 30 patients with inoperable stage III non-small cell lung cancer, used PET/CT planning radiation plan at 108 Military Central Hospital
12    26    1
Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: Associations with environmental factors and clinical outcomes

Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: Associations with environmental factors and clinical outcomes
9    1    1
Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection

Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection
8    1    1
Intraabdominal and ganglionic desmoplastic small round cell tumor: A case series

Intraabdominal and ganglionic desmoplastic small round cell tumor: A case series
6    15    1
Homoisopogon a from Ophiopogon japonicus induces apoptosis in A549 – a non small cell lung cancer cell line

Homoisopogon a from Ophiopogon japonicus induces apoptosis in A549 – a non small cell lung cancer cell line
5    61    0
Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with antiprogrammed cell death-1/ligand 1 inhibitors

Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with antiprogrammed cell death-1/ligand 1 inhibitors
8    92    0
Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells

Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells
14    93    0
Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016

Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016
8    56    1
Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells

Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells
16    63    1
Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelialmesenchymal transition signature and longer survival in squamous cell lung carcinoma

Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelialmesenchymal transition signature and longer survival in squamous cell lung carcinoma
10    51    1
A rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: An unusual morphological variant

A rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: An unusual morphological variant
4    36    1
Dual targeting of MEK and PI3K efectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with diferent genetic backgrounds

Dual targeting of MEK and PI3K efectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with diferent genetic backgrounds
12    38    1
Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression≥50%

Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression≥50%
12    1    1